SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Piramal Pharma’s consumer products division launches new digital campaign for 'Polycrol’

07 May 2024 Evaluate

Piramal Pharma’s Consumer Products Division (CPD) has launched its new digital campaign for 'Polycrol,' its trusted antacid brand, featuring actor, Jisshu Sengupta as the brand ambassador. This collaboration marks a significant milestone in Polycrol's journey to redefine the narrative surrounding digestive wellness. 

With a rich legacy spanning over four decades, Polycrol has earned the trust and confidence of millions, establishing itself as the go-to solution for those seeking quick and long lasting relief from acidity. Available in a mint and orange flavor, Polycrol is one of India’s leading liquid antacid brands, and is amongst the top 3 in Eastern India, including West Bengal, Assam and Odisha. It is also available in chewable tablets form. 

The campaign's central narrative revolves around a relatable scenario featuring Jisshu Sengupta as a corporate professional constantly prioritizing work over meals, leading to an inevitable encounter with acidity during a crucial presentation. In an era marked by fast-paced lifestyles and erratic eating habits, the campaign emphasizes the brand's reliability and effectiveness in providing timely relief, highlighting its role as a trusted companion in moments of need. Its high action formula starts action in 10 seconds and its highest ANP (Acid Neutralizing Potential) keeps a person relieved for long period of time.

Piramal Pharma provides end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.


Piramal Pharma Share Price

148.90 1.45 (0.98%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×